A cohort of 253 isolated LR resections from 3211 primary STS resections enabled evaluation of post-recurrence prognosticators with median 5.3-year follow-up and 83 disease-specific deaths. Higher LR ...

Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in ...

A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions. STS is a rare cancer that originates as an abnormal growth ...

Fragmented care — receiving medical treatment at more than one facility — has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...

Fragmented care - receiving medical treatment at more than one facility - has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...

Twenty-five patients were recruited in the study (14 male and 11 female patients). The median number of previous lines was 2 (2-4) with 76% exposed to pazopanib. The 3-month PFR was 56% with a median ...

COLUMBUS, Ohio – Pancreatic cancer blood tests, genetic predictors of breast cancer survival and sarcoma treatment response prediction tools are among the research topics being presented by scientists ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 24, Iovance Biotherapeutics announced positive early data from a pilot ...